Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
pembrolizumab in development Buyback: 6,000 Cr at 1,150/share signals management confidence in long-term value 19) Cipla US - Crossing $400 Mn Quarterly, Ventolin CGT Milestone FY26 US: ~$780 Mn | First AB-rated generic Ventolin with CGT approval Ciplas US business has been built methodically on respiratory leadership (inhaler franchise), and the generic Ventolin approval with Comparative Bioequivalence Study/CGT represents a significant competitive moat
As internal control, in PWA mice, generated by chronic exposure to exogenous DHT, circulating levels of this androgen were consistently elevated, without differences among the different experimental groups (Suppl
In contrast, long acting GLP-1 receptor agonists have relatively little effect on the rate of gastric emptying due to the development of tachyphylaxis resulting from continuous activation of the GLP-1 receptors in the GI tract (Nauck et al, 2011
Khan et al., 2019) (Table 1)
US$ 26.52
US$ 21.14
US$ 28.93
US$ 25.32
US$ 22.18
US$ 24.93
